Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Oncoimmunology
|
November 21, 2015
CAR-T cells are serial killers
Alexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
British Journal of Haematology
|
August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features
Saar Gill, Kirsten E Herbert, H Miles Prince, et al.
Nature Immunology
|
March 25, 2014
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J Chan, Ludovic Martinet, Susan Gilfillan, et al.
Blood
|
May 1, 2012
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill, Adrianne E Vasey, Alysha De Souza, et al.
British Journal of Haematology
|
July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia
Ashvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Blood
|
September 14, 2011
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma
Simon J Harrison, Hang Quach, Emma Link, et al.
Cancer Immunology Research
|
February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Alexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Leukemia & Lymphoma
|
July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant
Simon J Harrison, Andy K Hsu, Paul Neeson, et al.
Blood Advances
|
October 8, 2020
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
Joanne E Davis, Sasanka M Handunnetti, Mandy Ludford-Menting, et al.
Blood Neoplasia
|
November 24, 2025
T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
Rachel M Koldej, Allison Barraclough, Huw Morgan, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Oncoimmunology
|
November 21, 2015
CAR-T cells are serial killers
Alexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
British Journal of Haematology
|
August 22, 2009
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features
Saar Gill, Kirsten E Herbert, H Miles Prince, et al.
Nature Immunology
|
March 25, 2014
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J Chan, Ludovic Martinet, Susan Gilfillan, et al.
Blood
|
May 1, 2012
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill, Adrianne E Vasey, Alysha De Souza, et al.
British Journal of Haematology
|
July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia
Ashvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Blood
|
September 14, 2011
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma
Simon J Harrison, Hang Quach, Emma Link, et al.
Cancer Immunology Research
|
February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Alexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Leukemia & Lymphoma
|
July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant
Simon J Harrison, Andy K Hsu, Paul Neeson, et al.
Blood Advances
|
October 8, 2020
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
Joanne E Davis, Sasanka M Handunnetti, Mandy Ludford-Menting, et al.
Blood Neoplasia
|
November 24, 2025
T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
Rachel M Koldej, Allison Barraclough, Huw Morgan, et al.
Page
of 10